In COVID-19 clinical update #69, Daniel Griffin covers effectiveness of mRNA vaccines against the delta variant, depression among public health workers, correlates of protection against asymptomatic and symptomatic infection, BNT162b2 in ChAdOx-1-S primed individuals, prior infection rescues B and T cell responses to variants after vaccination, effect of vaccination on household transmission, germinal responses induced by mRNA vaccines, phase 3 results of Novavax vaccine, and long COVID as our next national health disaster.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Worry about human behavior, not variants (NY Times)
• Moderna and Pfizer vaccines vs delta variant
• Depression among public health workers (MMWR)
• Correlates of protection (medRxiv)
• mRNA vaccine in AZ recipients (Lancet)
• Prior infection rescues B and T cell responses to variants (Science)
• Effect of vaccination on household transmission (NEJM)
• mRNA vaccines induce germinal responses (Nature)
• Novavax vaccine phase 3 results (NEJM)
• EUA for tocilizumab (FDA)
• Long COVID, next national health disaster (NEJM)
• Letters read on TWiV 775
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]